However, its implementation has suggested future steps: 1) explore potential functions of this SNP that do not involve MARVELD3 (there is evidence that tyrosine aminotransferase may explain the association between malaria and this SNP [23]), or 2) see if MARVELD3 is detected in the next genomic screen for malaria resistance. The gene discussed is TAT; the disease is malaria.